Efficiency of Hepatitis B Vaccination;Zur Effizienz der Hepatitis B-Schutzimpfung

Gesundheitswesen

Volumn 59, Issue 8-9, 1997, Pages 527-534

  Hofmann, F ^a   Kralj, N ^a   Hasselhorn, H M ^a   Nubling M ^a   Michaelis, M ^a   Berthold, H ^a  

^a UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

Duration of protection; Hepatitis B vaccination; Low response; Non response

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; DISEASE TRANSMISSION; FEMALE; GERMANY; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME;

ADULT; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FEMALE; GERMANY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 0031196571     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Impfempfehlungen der Ständigen Impfkommission (STIKO), Stand: Oktober 1995, Infektionsepid. Forschung IV (1995) I-XII
2. Hofmann, F., H. Berthold: Zur Hepatitis B-Gefährdung des Krankenhauspersonals - Möglichkeiten der prae- und postex-positionellen Prophylaxe. Die Medizinische Welt 40 (1989) 1294-1301
3. Decker, R. H., L. R. Overby: Specific Problems of solid phase radioimmunoassays affecting the quality of performance. In: Rhodes, B. A., C. V. Mosby Co. (Hrsg.): Quality control of Nuclear Medicine. St. Louis M. O. (1977) 427-436
4. N. N.: Wochenstatistik ausgewählter Infektionskrankheiten. Epid. Bulletin 3 (1997)
5. Ayoola, E. A.: Viral Hepatitis in Africa. In: Zuckerman, A. (Hrsg.): Viral Hepatitis and Liver Disease. Alan R. Liss., New York (1988) 161-169
6. Bryan, J. P., M. Sjogren, M. Iqbal, A. Khattal Rauf, S. Nabi, A. Ahmed, B. Cox, A. Morton, J. Shuck, P. Macarthy, P. Ferine, I. Malik, L. J. Legters: Comparative Trial of Low-Dose, Intradermal, Recombinant- and Plasma-Derived Hepatitis-B-Vaccines. The Journ. of Inf. Dis. 162 (1990) 789-793
7. Coursaget, P., D. Leboulleux, M. Soumore, P. Le Cann: Twealve year follow-up-study of hepatitis B immunization of senegalese infants. J. Hepatology 21 (1994) 250-254
8. Del Canho, R., P. M. Grosheide, R. A. Heistink, S. W. Schalm: The course of hepatitis B in 9 children who became positive for viral surface antigen HBsAg in spile of vaccination (Niederlande). Ned. T. Geneeskunde 137 (1993) 2599-2603
9. Meheus, A., R. Klisjahbana, A. Vranckx, A. Sukadi et al.: Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates. Postgrad. Med. J. 63, Suppl. 2 (1987) 139-142
10. Dennhöfer, L: Hepatitis-B-Schutzimpfung - Zum Problem der ungenügenden Anti-HBs-Bildung. Dtsch. Med. Wschr. 115 (1990) 1560-1565
11. Krugman, S.: Hepatitis B vaccine. In: Plotkin, S. A., E. O. Mortimer (eds.): Vaccines. WB Sanders Co., Philadelphia (1988) pp 458-473
12. Jilg, W.: Experiences with the killed MSD-Hepatitis-A-vaccine. In: Hagberg, M. et al. (Hrsg.): Occupational Health for Health Care Workers; ecomed-Verlag, Landsberg 1993
13. Jilg, W.: Die aktuelle Schutzimpfung gegen Hepatitis B. Internist 25 (1985) 633-639
14. N. N.: Protection against viral hepatitis. Recommendations of the Immunization. Practises Advisory Committee (ACIP). Morb. Mort. Wkly. Rep. 39 (1990) 2-5